T2B Press Pass to JPM
***If you're a T2B member and do not receive your confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the Zoom info and cal invite.***
This pre-JPM webinar is complimentary for all T2B community members (both T2B Free and Pro).
If you're not part of Ticket to Biotech, confirm you're eligible, and click this button to join before registering for this event.
T2B PRESS PASS TO JPM: A PRE-CONFERENCE CONVERSATION WITH TOP REPORTERS
As we gear up for the JP Morgan Healthcare Conference (JPM) in January, it's time to talk to a few of the top reporters to hear what's on their mind and how we can support the stories they're looking to tell.
Open to all T2B community members, this is a panel with life science journalists and JPM veterans, Oliver Barnes (FT), Brad Loncar (BiotechTV), and Gabrielle Masson (Fierce Biotech). We'll explore their intended focus areas at JPM '25, the trends that will pique their interest for next year, and the sources and expertise they're looking for. We've scheduled this event to aid the T2B communicator community in forging meaningful connections with reporters right when outreach for JPM interactions begins.
KEY TAKEAWAYS
Gain exclusive insights into the journalistic focal points for JPM.
Understand the trends and topics that will dominate life science reporting in 2025.
Discover the companies and expertise journalists are eager to engage with.
Strategize your outreach effectively by knowing who to target for JPM meetings.
MEET OUR SPEAKERS
OLIVER BARNES, FT
Oliver Barnes is the FT’s US pharmaceutical and biotech correspondent based in New York, writing about scientific innovation, blockbuster drugs and access to healthcare in the world’s biggest economy. Oliver previously covered gambling, tobacco and hospitality companies as the FT’s leisure industries correspondent. He was nominated for a British Journalism Award for travel article of the year alongside colleagues for a features piece on extreme tourism.
His first role at the FT was covering health policy and science for the FT. He was awarded a journalism prize by the Royal Statistical Society for his coverage of the pandemic. Before joining the FT, Oliver worked for BBC News, writing articles for Reality Check, a BBC fact-checking service, and reporting for TV and radio outlets including the News at Six, Radio 4 and the World Service.
BRAD LONCAR, BIOTECHTV
Brad Loncar is the founder of BiotechTV, which offers news and features from across the biotech industry. Prior to this, he was a biotechnology industry investor and CEO of Loncar Investments and the creator of two Nasdaq-listed biotech focused exchange-traded funds. Brad previously worked in the financial services industry at Franklin Templeton Investments where he was a member of the Management Training Program, and was appointed to serve in a Senior Advisor role at the U.S. Department of the Treasury.
GABRIELLE MASSON, FIERCE BIOTECH
Gabrielle Masson is an associate editor for Fierce Biotech, where she engages in live and virtual events, frequently speaks on the Top Line Podcast, and has presented on the floor of the New York Stock Exchange.
Prior to Fierce, Gabrielle worked at Becker's Hospital Review, where she reported on public health and the pandemic. She has a background in data analysis and criminal justice, and graduated with a degree in creative writing after studying at the University of Wisconsin-Madison and the University of Cape Town.
Gabrielle is the recipient of a regional award for her headline writing and her creative writing has been featured in numerous publications.